- Describe new guidelines for the interpretation and reporting of echocardiographic findings in patients with aortic stenosis (AS)
- Identify and address challenges in the assessment of the severity of AS that may result in delayed referral to and intervention by the heart valve team
- Explain the benefits of transcatheter aortic valve replacement (TAVR) in patients with asymptomatic severe AS, including the impact of age and cardiac biomarkers on outcomes
- Implement emerging best practices for the management of AS, including enhanced communication between imaging specialists and other members of the heart valve team
Clearing the Way From Echo to AVR: Addressing Obstacles to Timely Intervention in Severe Aortic Stenosis
Please join us for a complimentary CME-certified dinner symposium
Saturday, November 8, 2025
5:30 PM – 6:00 PM CST Registration/Dinner
6:00 PM – 7:30 PM CST Scientific Session
Hilton New Orleans Riverside
Two Poydras Street
New Orleans, LA
Jefferson Ballroom, 3rd Floor
PROGRAM DESCRIPTION
Join the discussion with leading authorities in aortic valve replacement on the latest clinical trial data and expert recommendations, including how to ensure patient access to timely intervention. This CME symposium enables direct interaction with expert faculty to help you stay up-to-date with the recommended timing of optimal, evidence-based treatment delivered before irreversible cardiac damage occurs.
LEARNING OBJECTIVES
At the conclusion of this program, participants should be better able to:
INTENDED AUDIENCE
General cardiologists; internal medicine clinicians; and physicians, advanced practitioners, and other healthcare professionals who care for patients with aortic stenosis.
This event is not part of the official Scientific Sessions 2025 as planned by the AHA Committee on Scientific Sessions Programming.
Provided by Haymarket Medical Education
Supported by an educational grant from Edwards Lifesciences, LLC.